PharmaShots | Incisive News in 3 Shots

Subscribe Now

abcellera

AbCellera Enters into a Collaboration Agreement with Prelude Therapeutics to Develop Antibody Drug Conjugated to Treat Cancer

AbCellera Enters into a Collaboration Agreement with Prelude Therapeutics to Develop Antibody Drug Conjugated to Treat Cancer

November 2, 2023

AbCellera Collaborated with Rallybio to Develop and Commercialize Novel Antibody-Based Therapies for the Treatment of Rare Diseases

AbCellera Collaborated with Rallybio to Develop and Commercialize Novel Antibody-Based Therapies for the Treatment of Rare Disease...

December 1, 2022

AbCellera Collaborated with Atlas Venture to Discover Therapeutic Antibodies Against Three Drug Targets

AbCellera Collaborated with Atlas Venture to Discover Therapeutic Antibodies Against Three Drug Targets

August 3, 2022

PharmaShots Weekly Snapshots (October 11 - 15, 2021)

PharmaShots Weekly Snapshots (October 11 - 15, 2021)

October 15, 2021

PharmaShots Weekly Snapshots (September 20 - 24, 2021)

PharmaShots Weekly Snapshots (September 20 - 24, 2021)

September 24, 2021

PharmaShots Weekly Snapshots (August 02 - 06, 2021)

PharmaShots Weekly Snapshots (August 02 - 06, 2021)

August 6, 2021

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us